ADA2 Gene Polyarteritis nodosa childhood-onset Genetic Test
At DNA Labs UAE, we offer the ADA2 Gene Polyarteritis nodosa childhood-onset Genetic Test for individuals who are suspected of having this rare autoimmune disease. This test helps in the diagnosis and understanding of Polyarteritis nodosa (PAN), specifically childhood-onset PAN.
Test Details
The ADA2 gene is associated with childhood-onset PAN, a condition that affects the medium-sized arteries and causes inflammation and damage in various organs. Our Next-Generation Sequencing (NGS) technology allows us to analyze multiple genes simultaneously, enabling us to identify genetic variations or mutations in the ADA2 gene that may be responsible for the development of the disease.
Components
- Test Name: ADA2 Gene Polyarteritis nodosa childhood-onset Genetic Test
- Price: 4400.0 AED
- Sample Condition: Blood
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Vascular Diseases
- Doctor: General Physician
- Test Department: Genetics
Pre Test Information
Prior to undergoing the ADA2 Gene Polyarteritis nodosa childhood-onset Genetic Test, it is important for the patient to provide their clinical history. Additionally, a Genetic Counselling session may be conducted to draw a pedigree chart of family members affected by ADA2 Gene Polyarteritis nodosa, childhood-onset NGS Genetic DNA Test gene ADA2.
Benefits of NGS Genetic Testing
NGS genetic testing not only aids in the diagnosis of childhood-onset PAN, but also provides valuable information for genetic counseling and potential treatment options. By identifying mutations in the ADA2 gene, this test helps in understanding the underlying genetic mechanisms of the disease, which may contribute to the development of targeted therapies in the future.
Expert Interpretation and Guidance
Our NGS genetic testing is performed by qualified geneticists or genetic counselors who have the expertise to interpret the results accurately. Based on the findings, they provide appropriate guidance for further steps and potential treatment options.
At DNA Labs UAE, we are dedicated to providing accurate and reliable genetic testing services. Contact us today to schedule an appointment for the ADA2 Gene Polyarteritis nodosa childhood-onset Genetic Test.
| Test Name | ADA2 Gene Polyarteritis nodosa childhood-onset Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Vascular Diseases |
| Doctor | General Physician |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for ADA2 Gene Polyarteritis nodosa, childhood-onset NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ADA2 Gene Polyarteritis nodosa, childhood-onset NGS Genetic DNA Test gene ADA2 |
| Test Details | The ADA2 gene is associated with a condition called Polyarteritis nodosa (PAN), specifically childhood-onset PAN. PAN is a rare autoimmune disease that affects the medium-sized arteries, leading to inflammation and damage in various organs. NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously to identify genetic variations or mutations that may be associated with a particular condition. In the case of childhood-onset PAN, NGS genetic testing can be used to identify mutations in the ADA2 gene that may be responsible for the development of the disease. By identifying these mutations, NGS genetic testing can help with the diagnosis of childhood-onset PAN, as well as provide valuable information for genetic counseling and potential treatment options. It can also aid in understanding the underlying genetic mechanisms of the disease, which may contribute to the development of targeted therapies in the future. It is important to note that NGS genetic testing is typically performed by a qualified geneticist or genetic counselor, who will interpret the results and provide appropriate guidance based on the findings. |
